Dr Miranda Patterson Dr Nina Wilson Tara Homer Laura Simms Dr Alison Steel et al. | Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis | 2023 |
|
Dr Alaa Abouhajar Dr Lisa Alcock Dr Theophile Bigirumurame Penny Bradley Laura Brown et al. | Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy | 2022 |
|
Professor Phil White Dr Barbara Gregson Dr Adela Cora Dr Anand Dixit Dr Rachel Lakey et al. | Evaluation of stroke thrombectomy including patients where IV thrombolysis is contraindicated or has failed: A randomized trial of two novel thrombectomy devices | 2021 |
|
Professor Christopher Price Dr Lisa Shaw Dr Mehdi Javanbakht Dr Peter McMeekin Dr Darren Flynn et al. | Effect of an Enhanced Paramedic Acute Stroke Treatment Assessment (PASTA) on Thrombolysis Delivery During Emergency Stroke Care: A Cluster Randomised Clinical Trial | 2020 |
|
Professor Christopher Price Dr Lisa Shaw Professor Catherine Exley Dr Darren Flynn Emeritus Professor Roger Francis et al. | Paramedic Acute Stroke Treatment Assessment (PASTA): study protocol for a randomised controlled trial | 2019 |
|
Professor Christopher Price Dr Stuart Huntley Dr Rachel Lakey
| Estimated GFR and the Effect of Intensive Blood Pressure Lowering after Acute Intracerebral Hemorrhage | 2016 |
|
Professor Phil White Dr Rachel Lakey
| Observer Reliability of CT Angiography in the assessment of acute ischaemic stroke: Data from the Third International Stroke Trial | 2015 |
|
Mark Houseman Dr Kate Potter Nicola Marshall Dr Rachel Lakey Emeritus Professor Tim Cawston et al. | Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up | 2012 |
|
Professor Phil White Dr Rachel Lakey
| The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial | 2012 |
|
Dr Kenneth Rankin Dr Rachel Lakey Craig Gerrand Andrew Sprowson Professor Andrew McCaskie et al. | A Novel in Vitro Model to Investigate Behavior of Articular Chondrocytes in Osteoarthritis | 2010 |
|
Emeritus Professor Tim Cawston Dr Rachel Lakey Emeritus Professor Drew Rowan
| Assay of matrix metalloproteinases against matrix substrates | 2010 |
|
Dr Matthew Barter Dr Rachel Lakey Dr Jonathan Catterall Emeritus Professor Tim Cawston Professor David Young et al. | Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation | 2010 |
|
Dr Rachel Lakey Emeritus Professor Drew Rowan Professor John Isaacs Emeritus Professor Tim Cawston Professor Catharien Hilkens et al. | A novel paradigm for dendritic cells as effectors of cartilage destruction | 2009 |
|
Dr Rachel Lakey Emeritus Professor Tim Cawston
| Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases | 2009 |
|
Dr Kenneth Rankin Dr Rachel Lakey Craig Gerrand Andrew Sprowson Professor Andrew McCaskie et al. | A novel in vitro model of osteoarthritis facilitates improved understanding of human articular chondrocyte behaviour | 2008 |
|
Dr Kenneth Rankin Craig Gerrand Dr Rachel Lakey Andrew Sprowson Professor Andrew McCaskie et al. | Hypoxia facilitates bone invasion by increasing breast cancer cell expression of matrix metalloproteinase-1 | 2008 |
|
Dr Gary Litherland Dr Craig Dixon Dr Rachel Lakey Tim Robson David Jones et al. | Synergistic collagenase expression and cartilage collagenolysis are phosphatidylinositol 3-kinase/Akt signaling-dependent | 2008 |
|
Emeritus Professor Tim Cawston Dr Rachel Lakey Debra Jones Dr Jonathan Catterall Emeritus Professor Robin Seymour et al. | Gingival fibroblasts grown from cyclosporin-treated patients show a reduced production of matrix metalloproteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin down-regulates the production of MMP-1 stimulated by pro-inflammatory cytokines | 2007 |
|
Dr Jonathan Catterall Dr Rachel Lakey Emeritus Professor Tim Cawston
| Investigation into the potential chondroprotective effects of ciclosporin in arthritis | 2006 |
|
Dr Emma Barksby Dr Jenny Milner Dr Angela Patterson Dr Nicholas Peake Tim Robson et al. | Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: Implications for cartilage degradation in arthritis | 2006 |
|
Dr Rachel Lakey Dr Jonathan Catterall Emeritus Professor Tim Cawston
| Mevastatin and simvastatin block collagen release from bovine cartilage and downregulate MMP-13 from human articular chondrocytes | 2006 |
|
Professor David Young Dr Rachel Lakey Professor David Jones Emeritus Professor Tim Cawston
| Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption | 2005 |
|
Professor David Young Dr Rachel Lakey David Jones Emeritus Professor Tim Cawston
| Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption | 2005 |
|
Professor David Young Dr Rachel Lakey David Jones Emeritus Professor Tim Cawston
| Oncostatin M in combination with tumour necrosis factor alpha induces a chondrocyte membrane-associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2 | 2005 |
|
Professor David Young Dr Rachel Lakey Emeritus Professor Tim Cawston
| Histone deacetylase inhibitors are chondroprotective | 2004 |
|
Dr Andrea Myers Dr Rachel Lakey Emeritus Professor Tim Cawston Dr Lesley Kay
| Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblings | 2004 |
|